Treatment Approach for Rare Histologic Subtypes of Breast Cancer: A Review

키워드

참고문헌 (87)

1. Baliu-Piqué M, "Breast cancer heterogeneity and response to novel therapeutics", Cancers, 12, pp.3271~ (2020)
2. Brenton JD, "Molecular classification and molecular forecasting of breast cancer : ready for clinical application?", J Clin Oncol, 23, pp.7350~7360 (2005)
3. Tan PH, "The 2019 World Health Organization classification of tumours of the breast", Histopathology, 77, pp.181~185 (2020)
4. Orrantia-Borunda E, "Breast Cancer" (2022), Exon Publications
5. Perou CM, "Molecular portraits of human breast tumours", Nature, 406, pp.747~752 (2000)
6. "NCCN Clinical Practice Guidelines in oncology: Breast (Version 2. 2024)"[URL]
7. Dieci MV, "Rare breast cancer subtypes : histological, molecular, and clinical peculiarities", Oncologist, 19, pp.805~813 (2014)
8. Cserni G, "Histological type and typing of breast carcinomas and the WHO classification changes over time", Pathologica, 112, pp.25~41 (2020)
9. Rosen PP, "Rosen’s breast pathology" (2001), Lippincott Williams & Wilkins
10. Ellis I, "Invasive breast carcinoma, pathology and genetics of tumours of the breast and female genital organs" (2003), IARC Press
11. Rakha EA, "Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast", Breast Cancer Res Treat, 111, pp.121~127 (2008)
12. Louwman MW, "Uncommon breast tumors in perspective : incidence, treatment and survival in the Netherlands", Int J Cancer, 121, pp.127~135 (2007)
13. Waks AG, "Breast cancer treatment : a review", JAMA, 321, pp.288~300 (2019)
14. Hoda SA, "World Health Organization(WHO)classification of breast tumours, 4th ed", Am J Surg Pathol, 37, pp.309~310 (2013)
15. Anderson WF, "Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma", Cancer Epidemiol Biomarkers Prev, 13, pp.1128~1135 (2004)
16. Di Saverio S, "A retrospective review with long term follow up of 11, 400 cases of pure mucinous breast carcinoma", Breast Cancer Res Treat, 111, pp.541~547 (2008)
17. Clayton F, "Pure mucinous carcinomas of breast : morphologic features and prognostic correlates", Hum Pathol, 17, pp.34~38 (1986)
18. Tan PH, "Mucinous breast lesions : diagnostic challenges", J Clin Pathol, 61, pp.11~19 (2008)
19. Skotnicki P, "Pure and mixed mucinous carcinoma of the breast : a comparison of clinical outcomes and treatment results", Breast J, 22, pp.529~534 (2016)
20. Kashiwagi S, "Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma", SpringerPlus, 2, pp.481~ (2013)
21. Ranade A, "Clinicopathological evaluation of 100 cases of mucinous carcinoma of breast with emphasis on axillary staging and special reference to a micropapillary pattern", J Clin Pathol, 63, pp.1043~1047 (2010)
22. Bae SY, "Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma : clinicopathologic characteristics and prognosis", J Breast Cancer, 14, pp.308~313 (2011)
23. Limaiem F, "Tubular breast carcinoma" (2024), StatPearls Publishing
24. Fasano M, "Tubular carcinoma of the breast : immunohistochemical and DNA flow cytometric profile", Breast J, 5, pp.252~255 (1999)
25. Berg JW, "Breast cancer", Cancer, 75(Suppl 1), pp.257~269 (1995)
26. Sun JY, "Tubular carcinomas of the breast : an epidemiologic study", Future Oncol, 14, pp.3037~3047 (2018)
27. Romano AM, "Tubular carcinoma of the breast : institutional and SEER database analysis supporting a unique classification", Breast Dis, 35, pp.103~111 (2015)
28. Page DL, "Invasive cribriform carcinoma of the breast", Histopathology, 7, pp.525~536 (1983)
29. Venable JG, "Infiltrating cribriform carcinoma of the breast : a distinctive clinicopathologic entity", Hum Pathol, 21(3), pp.333~338 (1990)
30. Stutz JA, "The radiological appearances of invasive cribriform carcinoma of the breast", Clin Radiol, 49, pp.693~695 (1994)
31. Lakhani SR, "WHO Classification of Tumours of the Breast" (2012), IARC
32. Ellis IO, "Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up", Histopathology, 20, pp.479~489 (1992)
33. Sparano JA, "Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer", N Engl J Med, 379, pp.111~121 (2018)
34. Cobb AN, "Breast cancer subtypes : clinicopathologic features and treatment considerations", Curr Breast Cancer Rep, 16, pp.150~160 (2024)
35. Tadros AB, "Breast cancers of special histologic subtypes are biologically diverse", Ann Surg Oncol, 25, pp.3158~3164 (2018)
36. Miyai K, "Adenoid cystic carcinoma of breast : recent advances", World J Clin Cases, 2, pp.732~741 (2014)
37. Ghabach B, "Adenoid cystic carcinoma of the breast in the United States(1977 to 2006) : a population-based cohort study", Breast Cancer Res, 12, pp.R54~ (2010)
38. Kim M, "Adenoid cystic carcinoma of the breast : a case series of six patients and literature review", Cancer Res Treat, 46, pp.93~97 (2014)
39. Arpino G, "Adenoid cystic carcinoma of the breast : molecular markers, treatment, and clinical outcome", Cancer, 94, pp.2119~2127 (2002)
40. Thomas DN, "Adenoid cystic carcinoma of the breast", J Surg Case Rep, 2019, pp.rjy355~ (2019)
41. Tavassoli F, "tumors of the breast and female genital organs", pp.13~48 (2003), IARC
42. McDivitt RW, "Breast carcinoma in children", JAMA, 195, pp.388~390 (1966)
43. Sharma R, "Secretory carcinoma of breast in an elderly female", Indian J Pathol Microbiol, 44, pp.449~450 (2001)
44. Hoda RS, "Secretory carcinoma of the breast : clinicopathologic profile of 14 cases emphasising distant metastatic potential", Histopathology, 75, pp.213~224 (2019)
45. Li D, "Secretory breast carcinoma : a clinicopathological and immunophenotypic study of 15 cases with a review of the literature", Mod Pathol, 25, pp.567~575 (2012)
46. Horowitz DP, "Secretory carcinoma of the breast : results from the survival, epidemiology and end results database", Breast, 21, pp.350~353 (2012)
47. Jacob JD, "Rare breast cancer : 246 invasive secretory carcinomas from the National Cancer Data Base", J Surg Oncol, 113, pp.721~725 (2016)
48. Podetta M, "Low-grade fibromatosis-like spindle cell metaplastic carcinoma : a basal-like tumor with a favorable clinical outcome. Report of two cases", Tumori, 95, pp.264~267 (2009)
49. Van Hoeven KH, "Low-grade adenosquamous carcinoma of the breast. A clinocopathologic study of 32 cases with ultrastructural analysis", Am J Surg Pathol, 17, pp.248~258 (1993)
50. Yang L, "Evaluation of adjuvant treatments for adenoid cystic carcinoma of the breast : a population-based, propensity score matched cohort study from the SEER database", Diagnostics, 12, pp.1760~ (2022)
51. Zhang G, "Low-grade adenosquamous carcinoma of the breast", Hum Pathol Rep, 26, pp.300568~ (2021)
52. Carter MR, "Spindle cell(sarcomatoid)carcinoma of the breast : a clinicopathologic and immunohistochemical analysis of 29 cases", Am J Surg Pathol, 30, pp.300~309 (2006)
53. Kunkler IH, "Breast-conserving surgery with or without irradiation in early breast cancer", N Engl J Med, 388, pp.585~594 (2023)
54. Mo Q, "Effect of postoperative radiotherapy in women with localized pure mucinous breast cancer after lumpectomy : a population-based study", Radiat Oncol, 17, pp.119~ (2022)
55. Coates JM, "Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast", J Surg Oncol, 102, pp.342~347 (2010)
56. Sun JY, "Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast", Breast, 31, pp.214~218 (2017)
57. Tatebe K, "Hypofractionated radiation in secretory breast cancer : a case report", Rare Tumors, 13, pp.20363613211045252~ (2021)
58. Cui ZQ, "Clinicopathological features of invasive micropapillary carcinoma of the breast", Oncology Lett, 9, pp.1163~1166 (2015)
59. Li W, "Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast : a 12-year prospective clinical study", Mod Pathol, 31, pp.956~964 (2018)
60. Middleton LP, "Infiltrating micropapillary carcinoma of the breast", Mod Pathol, 12, pp.499~504 (1999)
61. Luna-Moré S, "Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54", Pathol Res Prac, 196, pp.35~39 (2000)
62. Pettinato G, "Invasive micropapillary carcinoma of the breast : clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior", Am J Clin Pathol, 121, pp.857~866 (2004)
63. Yoon GY, "Comparison of invasive micropapillary and invasive ductal carcinoma of the breast : a matched cohort study", Acta radiologica, 60, pp.1405~1413 (2019)
64. Hao S, "Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma : a propensity-matched analysis", Sci Rep, 9, pp.286~ (2019)
65. Mercogliano MF, "TNF-induced nucin 4 expression elicits trastuzumab resistance in HER2-positive breast cancer", Clin Cancer Res, 23, pp.636~648 (2017)
66. Mercogliano MF, "Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer", BMC Cancer, 17, pp.895~ (2017)
67. Nakajima H, "Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer", Breast, 61, pp.136~144 (2022)
68. Chang DY, "Role of alpelisib in the treatment of PIK3CA-mutated breast cancer : patient selection and clinical perspectives", Ther Clin Risk Manag, 17, pp.193~207 (2021)
69. Cooper CL, "Molecular alterations in metaplastic breast carcinoma", J Clin Pathol, 66, pp.522~528 (2013)
70. Leddy R, "Review of metaplastic carcinoma of the breast : imaging findings and pathologic features", J Clin Imaging Sci, 2, pp.21~ (2012)
71. Tse G, "Metaplastic carcinoma of the breast : a clinicopathological review", J Clin Pathol, 59, pp.1079~1083 (2006)
72. González-Martínez S, "Molecular features of metaplastic breast carcinoma : an infrequent subtype of triple negative breast carcinoma", Cancers, 12, pp.1832~ (2020)
73. Krings G, "Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma", Mod Pathol, 31, pp.1661~1674 (2018)
74. Ng CKY, "The landscape of somatic genetic alterations in metaplastic breast carcinomas", Clin Cancer Res, 23, pp.3859~3870 (2017)
75. Bae SY, "The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients", Breast Cancer Res Treat, 126, pp.471~478 (2011)
76. Nagao T, "The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy : the relationship between the outcome and the clinicopathological characteristics", Breast, 21, pp.289~295 (2012)
77. Pezzi CM, "Characteristics and treatment of metaplastic breast cancer : analysis of 892 cases from the National Cancer Data Base", Ann Surg Oncol, 14, pp.166~173 (2007)
78. El Zein D, "Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer : a study from a single institution and review of literature", Clin Breast Cancer, 17, pp.382~391 (2017)
79. Asselain B, "Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials", Lancet Oncol, 19, pp.27~39 (2018)
80. Haque W, "Neoadjuvant chemotherapy for metaplastic breast cancer : response rates, management, and outcomes", Clin Breast Cancer, 22, pp.e691~e699 (2022)
81. Corso G, "Metaplastic breast cancer : prognostic and therapeutic considerations", J Surg Oncol, 123, pp.61~70 (2021)
82. Wong W, "Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma", NPJ Breast Cancer, 7, pp.96~ (2021)
83. Joneja U, "Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1", J Clin Pathol, 70, pp.255~259 (2017)
84. Cortes J, "Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer", N Engl J Med, 387, pp.217~226 (2022)
85. Schmid P, "Pembrolizumab for early triple-negative breast cancer", N Engl J Med, 382, pp.810~821 (2020)
86. Adams S, "Dramatic response of metaplastic breast cancer to chemo-immunotherapy", NPJ Breast Cancer, 3, pp.8~ (2017)
87. Gul A, "A case of pathologic complete response to neoadjuvant chemotherapy and pembrolizumab in metaplastic breast cancer", JCO Precis Oncol, 7, pp.e2200506~ (2023)

관련 논문AI추천